---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-075412"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2023-09-08T23:59:59+00:00"
generated_at: "2026-06-10T22:14:32.851829+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Nasdaq notified on Sept 7, 2023 that ATNF failed minimum bid price of $1.00 for 30 consecutive business days.
- Company has until March 5, 2024 (180 days) to regain compliance with closing bid >= $1.00 for 10 consecutive days.
- If not compliant by then, an additional 180 days may be granted if company meets other initial listing criteria and intends to cure via reverse stock split.
- Company intends to monitor bid price and consider available options to regain compliance.

## SEC filing metadata
- accession: 0001213900-23-075412
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2023-09-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390023075412/0001213900-23-075412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390023075412/ea184888-8k_180life.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-075412
- JSON: https://secwatch.observer/filing/0001213900-23-075412.json
- Plain text: https://secwatch.observer/filing/0001213900-23-075412.txt

## Key facts
- Listing & Compliance Notices
  FORUM MARKETS Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: September 7, 2023, 180 Life Sciences Corp. (the “ Company ”, “ we ” or “ us ”) received written notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid pric
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390023075412/0001213900-23-075412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.